Cargando…

Systematic Evaluation of the Cellular Innate Immune Response During the Process of Human Atherosclerosis

BACKGROUND: The concept of innate immunity is well recognized within the spectrum of atherosclerosis, which is primarily dictated by macrophages. Although current insights to this process are largely based on murine models, there are fundamental differences in the atherosclerotic microenvironment an...

Descripción completa

Detalles Bibliográficos
Autores principales: van Dijk, Rogier A., Rijs, Kevin, Wezel, Anouk, Hamming, Jaap F., Kolodgie, Frank D., Virmani, Renu, Schaapherder, Alexander F., Lindeman, Jan H. N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937250/
https://www.ncbi.nlm.nih.gov/pubmed/27312803
http://dx.doi.org/10.1161/JAHA.115.002860
_version_ 1782441674735091712
author van Dijk, Rogier A.
Rijs, Kevin
Wezel, Anouk
Hamming, Jaap F.
Kolodgie, Frank D.
Virmani, Renu
Schaapherder, Alexander F.
Lindeman, Jan H. N.
author_facet van Dijk, Rogier A.
Rijs, Kevin
Wezel, Anouk
Hamming, Jaap F.
Kolodgie, Frank D.
Virmani, Renu
Schaapherder, Alexander F.
Lindeman, Jan H. N.
author_sort van Dijk, Rogier A.
collection PubMed
description BACKGROUND: The concept of innate immunity is well recognized within the spectrum of atherosclerosis, which is primarily dictated by macrophages. Although current insights to this process are largely based on murine models, there are fundamental differences in the atherosclerotic microenvironment and associated inflammatory response relative to humans. In this light, we characterized the cellular aspects of innate immune response in normal, nonprogressive, and progressive human atherosclerotic plaques. METHODS AND RESULTS: A systematic analysis of innate immune response was performed on 110 well‐characterized human perirenal aortic plaques with immunostaining for specific macrophage subtypes (M1 and M2 lineage) and their activation markers, neopterin and human leukocyte antigen–antigen D related (HLA‐DR), together with dendritic cells (DCs), natural killer (NK) cells, mast cells, neutrophils, and eosinophils. Normal aortae were devoid of low‐density lipoprotein, macrophages, DCs, NK cells, mast cells, eosinophils, and neutrophils. Early, atherosclerotic lesions exhibited heterogeneous populations of (CD68(+)) macrophages, whereby 25% were double positive “M1” (CD68(+)/ inducible nitric oxide synthase [iNOS](+)/CD163(−)), 13% “M2” double positive (CD68(+)/iNOS (−)/CD163(+)), and 17% triple positive for (M1) iNOS (M2)/CD163 and CD68, with the remaining (≈40%) only stained for CD68. Progressive fibroatheromatous lesions, including vulnerable plaques, showed increasing numbers of NK cells and fascin‐positive cells mainly localized to the media and adventitia whereas the M1/M2 ratio and level of macrophage activation (HLA‐DR and neopterin) remained unchanged. On the contrary, stabilized (fibrotic) plaques showed a marked reduction in macrophages and cell activation with a concomitant decrease in NK cells, DCs, and neutrophils. CONCLUSIONS: Macrophage “M1” and “M2” subsets, together with fascin‐positive DCs, are strongly associated with progressive and vulnerable atherosclerotic disease of human aorta. The observations here support a more complex theory of macrophage heterogeneity than the existing paradigm predicated on murine data and further indicate the involvement of (poorly defined) macrophage subtypes or greater dynamic range of macrophage plasticity than previously considered.
format Online
Article
Text
id pubmed-4937250
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-49372502016-07-18 Systematic Evaluation of the Cellular Innate Immune Response During the Process of Human Atherosclerosis van Dijk, Rogier A. Rijs, Kevin Wezel, Anouk Hamming, Jaap F. Kolodgie, Frank D. Virmani, Renu Schaapherder, Alexander F. Lindeman, Jan H. N. J Am Heart Assoc Original Research BACKGROUND: The concept of innate immunity is well recognized within the spectrum of atherosclerosis, which is primarily dictated by macrophages. Although current insights to this process are largely based on murine models, there are fundamental differences in the atherosclerotic microenvironment and associated inflammatory response relative to humans. In this light, we characterized the cellular aspects of innate immune response in normal, nonprogressive, and progressive human atherosclerotic plaques. METHODS AND RESULTS: A systematic analysis of innate immune response was performed on 110 well‐characterized human perirenal aortic plaques with immunostaining for specific macrophage subtypes (M1 and M2 lineage) and their activation markers, neopterin and human leukocyte antigen–antigen D related (HLA‐DR), together with dendritic cells (DCs), natural killer (NK) cells, mast cells, neutrophils, and eosinophils. Normal aortae were devoid of low‐density lipoprotein, macrophages, DCs, NK cells, mast cells, eosinophils, and neutrophils. Early, atherosclerotic lesions exhibited heterogeneous populations of (CD68(+)) macrophages, whereby 25% were double positive “M1” (CD68(+)/ inducible nitric oxide synthase [iNOS](+)/CD163(−)), 13% “M2” double positive (CD68(+)/iNOS (−)/CD163(+)), and 17% triple positive for (M1) iNOS (M2)/CD163 and CD68, with the remaining (≈40%) only stained for CD68. Progressive fibroatheromatous lesions, including vulnerable plaques, showed increasing numbers of NK cells and fascin‐positive cells mainly localized to the media and adventitia whereas the M1/M2 ratio and level of macrophage activation (HLA‐DR and neopterin) remained unchanged. On the contrary, stabilized (fibrotic) plaques showed a marked reduction in macrophages and cell activation with a concomitant decrease in NK cells, DCs, and neutrophils. CONCLUSIONS: Macrophage “M1” and “M2” subsets, together with fascin‐positive DCs, are strongly associated with progressive and vulnerable atherosclerotic disease of human aorta. The observations here support a more complex theory of macrophage heterogeneity than the existing paradigm predicated on murine data and further indicate the involvement of (poorly defined) macrophage subtypes or greater dynamic range of macrophage plasticity than previously considered. John Wiley and Sons Inc. 2016-06-16 /pmc/articles/PMC4937250/ /pubmed/27312803 http://dx.doi.org/10.1161/JAHA.115.002860 Text en © 2016 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Research
van Dijk, Rogier A.
Rijs, Kevin
Wezel, Anouk
Hamming, Jaap F.
Kolodgie, Frank D.
Virmani, Renu
Schaapherder, Alexander F.
Lindeman, Jan H. N.
Systematic Evaluation of the Cellular Innate Immune Response During the Process of Human Atherosclerosis
title Systematic Evaluation of the Cellular Innate Immune Response During the Process of Human Atherosclerosis
title_full Systematic Evaluation of the Cellular Innate Immune Response During the Process of Human Atherosclerosis
title_fullStr Systematic Evaluation of the Cellular Innate Immune Response During the Process of Human Atherosclerosis
title_full_unstemmed Systematic Evaluation of the Cellular Innate Immune Response During the Process of Human Atherosclerosis
title_short Systematic Evaluation of the Cellular Innate Immune Response During the Process of Human Atherosclerosis
title_sort systematic evaluation of the cellular innate immune response during the process of human atherosclerosis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937250/
https://www.ncbi.nlm.nih.gov/pubmed/27312803
http://dx.doi.org/10.1161/JAHA.115.002860
work_keys_str_mv AT vandijkrogiera systematicevaluationofthecellularinnateimmuneresponseduringtheprocessofhumanatherosclerosis
AT rijskevin systematicevaluationofthecellularinnateimmuneresponseduringtheprocessofhumanatherosclerosis
AT wezelanouk systematicevaluationofthecellularinnateimmuneresponseduringtheprocessofhumanatherosclerosis
AT hammingjaapf systematicevaluationofthecellularinnateimmuneresponseduringtheprocessofhumanatherosclerosis
AT kolodgiefrankd systematicevaluationofthecellularinnateimmuneresponseduringtheprocessofhumanatherosclerosis
AT virmanirenu systematicevaluationofthecellularinnateimmuneresponseduringtheprocessofhumanatherosclerosis
AT schaapherderalexanderf systematicevaluationofthecellularinnateimmuneresponseduringtheprocessofhumanatherosclerosis
AT lindemanjanhn systematicevaluationofthecellularinnateimmuneresponseduringtheprocessofhumanatherosclerosis